FAM83B has been implicated as a mediator of EGFR‐RAS‐MAPK‐driven oncogenic transformation, and an increase in FAM83B gene expression was also observed in different tumor types, associated with increased tumor grade and decreased patient survival (Cipriano et al., 2012). Here, EGFR is linked to neoplasm.